There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.

Biologics Quality Control: The Growing Need for Accessible Proteomics

The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.

Emerging Therapies Drive Analytical Advancements

Effective analytics will eliminate failures, deviations, and non-conformances.

 Analyzing Exabytes

Topic

Articles

The committee has voted unanimously to approve Spark Therapeutics’ gene therapy candidate, Luxturna (voretigene neparvovec), for treating a genetically inherited blindness.

FDA Committee Recommends Approval of Spark’s Eye-Disease Gene Therapy

The companies have entered into a strategic collaboration to establish a new cell therapy and regenerative medicine manufacturing platform, which includes a new manufacturing facility in Belgium.

Promethera and Shibuya Partner on New Cell-Therapy Manufacturing Platform

Fluence Analytics’ Argen is a protein and polymer stability monitoring product that uses continuous light scattering measurements to produce an information stream.

Instrument for Continuous Protein and Polymer Aggregation Analysis

Amgen is seeking approval for an additional indication in glucocorticoid-induced osteoporosis for its blockbuster osteoporosis therapeutic, Prolia.

FDA Accepts Amgen’s Application for New Indication of Osteoporosis Biologic

AstraZeneca is seeking approval for its anti-cancer monoclonal antibody, Imfinzi, for treating non-small cell lung cancer in the European Union.

EMA Accepts AstraZeneca’s Application for Lung Cancer Biologic

BARDA has entered a $12-million contract with biopharmaceutical firm Achaogen for the late-stage development of an antibiotic against resistant bacteria, and as a potential treatment for biowarfare agents.

HHS Sponsors Development of Antibiotic-Resistant, Anti-Biowarfare Antibiotic

Johnson & Johnson’s Janssen Sciences Ireland UC will invest more than EUR 300 million (US$355 million) to expand manufacturing capacity for biologic medicines at its Ireland facility.

J&J Invests in Biologic Manufacturing Capacity Expansion in Ireland

Clariant’s Tri-Sorb Desiccant Tablets are designed for USP  moisture testing of blister packs. 


Desiccant Tablets Measure Moisture in Blister Pack Testing

Under an agreement, ProBioGen will develop a stable cell-line for and manufacture an anti-cancer antibody for Chiome using its proprietary cancer cell-killing technology.

ProBioGen and Chiome in Antibody Manufacturing Deal

Tools aid scale-up and comparison of single-use and stainless-steel bioreactors.